SOLID CANCER
Clinical trials for SOLID CANCER explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCER trials appear
Sign up with your email to follow new studies for SOLID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mushroom compound may revive immune system in cancer survivors
Disease control Recruiting nowThis study tests a mushroom-derived supplement called cordycepin (PRaG-1) in 127 adults who had solid tumors and are now cancer-free for at least six months after radiation or chemotherapy, but have low levels of CD8+ immune cells. Participants take the supplement for two weeks, …
Matched conditions: SOLID CANCER
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for advanced cancer? AK138D1 enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called AK138D1 in up to 200 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and find the best dose. Researchers will also look for early signs that the drug can…
Matched conditions: SOLID CANCER
Phase: PHASE1 • Sponsor: Akeso • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New cell therapy trial targets Hard-to-Treat solid tumors
Disease control Recruiting nowThis early-phase trial is testing a new treatment called TC-G203 for people with advanced solid tumors that have a specific marker (GPC3) and have not responded to standard therapies. The main goal is to find the safest dose and check for side effects. About 30 adults will take p…
Matched conditions: SOLID CANCER
Phase: EARLY_PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug offers hope for women with resistant ovarian cancer
Disease control Recruiting nowThis study is testing a new drug called R-DXd in people with ovarian, peritoneal, or fallopian tube cancer that no longer responds to platinum chemotherapy. The drug works like a guided missile, targeting a protein on cancer cells to deliver a powerful toxin. The trial will measu…
Matched conditions: SOLID CANCER
Phase: PHASE2, PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
Could a pomegranate metabolite boost cancer immunotherapy?
Knowledge-focused Recruiting nowThis study tests whether urolithin A, a natural compound, can improve how the immune system responds to standard immunotherapy in people with solid tumors like lung cancer or melanoma. About 45 participants who have not had prior cancer treatment will receive either urolithin A o…
Matched conditions: SOLID CANCER
Phase: NA • Sponsor: Goethe University • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC